SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $18,000 | -45.5% | 190 | -55.0% | 0.00% | -42.9% |
| Q2 2021 | $33,000 | +17.9% | 422 | +10.5% | 0.01% | +16.7% |
| Q1 2021 | $28,000 | -22.2% | 382 | +78.5% | 0.01% | -25.0% |
| Q4 2020 | $36,000 | +9.1% | 214 | -9.3% | 0.01% | -11.1% |
| Q3 2020 | $33,000 | -2.9% | 236 | +9.8% | 0.01% | -18.2% |
| Q2 2020 | $34,000 | +41.7% | 215 | -13.0% | 0.01% | +10.0% |
| Q1 2020 | $24,000 | -7.7% | 247 | +24.1% | 0.01% | +42.9% |
| Q4 2019 | $26,000 | +2500.0% | 199 | +1143.8% | 0.01% | – |
| Q3 2019 | $1,000 | -96.0% | 16 | -90.2% | 0.00% | -100.0% |
| Q2 2019 | $25,000 | – | 164 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |